Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation
Open Access
- 27 August 2004
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 11 (9) , 625-632
- https://doi.org/10.1038/sj.cgt.7700740
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Possible Involvement of Antitumor Immunity in the Eradication of Colon 26 Induced by Low-Voltage Electrochemotherapy with BleomycinSurgery Today, 2003
- Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: Inhibition of primary tumor growth and metastatic spreadCancer Gene Therapy, 2002
- Intramuscular electroporation delivery of IFN-α gene therapy for inhibition of tumor growth located at a distant siteGene Therapy, 2001
- Combination Angiostatin and Endostatin Gene Transfer Induces Synergistic Antiangiogenic Activity in Vitro and Antitumor Efficacy in Leukemia and Solid Tumors in MiceMolecular Therapy, 2001
- Theory and in Vivo Application of Electroporative Gene DeliveryMolecular Therapy, 2000
- Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activityJournal of Molecular Biology, 2000
- Electroporation-enhanced gene delivery in mammary tumorsGene Therapy, 2000
- Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppressionNature Medicine, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Study of mechanisms of electric field-induced DNA transfection. I. DNA entry by surface binding and diffusion through membrane poresBiophysical Journal, 1990